Chemical subtleties in small-molecule modulation of peptide receptor function: The case of CXCR3 biaryl-type ligands

Journal of Medicinal Chemistry

Volumn 55, Issue 23, 2012, Pages 10572-10583

  Wijtmans, Maikel ^a   Scholten, Danny J ^a   Roumen, Luc ^a   Canals, Meritxell ^a,b   Custers, Hans ^a   Glas, Marjolein ^a   Vreeker, Marlies C A ^a   De Kanter, Frans J J ^a   De Graaf, Chris ^a   Smit, Martine J ^a   De Esch, Iwan J P ^a   Leurs, Rob ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR3; UNCLASSIFIED DRUG; VUF 11222; VUF 11418;

ARTICLE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN FUNCTION; QUANTUM MECHANICS; STRUCTURE ACTIVITY RELATION;

LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; RECEPTORS, CXCR3; RECEPTORS, PEPTIDE; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84871018915     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301240t     Document Type: Article

References (36)

1. Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How many drug targets are there? Nat. Rev. Drug Discovery 2006, 5, 993-996
2. Scholten, D.; Canals, M.; Maussang, D.; Roumen, L.; Smit, M.; Wijtmans, M.; de Graaf, C.; Vischer, H.; Leurs, R. Pharmacological modulation of chemokine receptor function Br. J. Pharmacol. 2012, 165, 1617-1643
3. Viola, A.; Luster, A. D. Chemokines and their receptors: drug targets in immunity and inflammation Annu. Rev. Pharmacol. Toxicol. 2008, 48, 171-197
4. Medina, J. C.; Johnson, M. G.; Collins, T. L. CXCR3 antagonists Annu. Rep. Med. Chem. 2005, 40, 215-225
5. Wijtmans, M.; Verzijl, D.; Leurs, R.; de Esch, I. J.; Smit, M. J. Towards small-molecule CXCR3 ligands with clinical potential ChemMedChem 2008, 3, 861-872
6. Wijtmans, M.; de Esch, I. J. P.; Leurs, R. In Chemokine Receptors as Drug Targets; Smit, M. J.; Lira, S. A.; Leurs, R., Eds.; Wiley-VCH: Weinheim, Germany, 2011; pp 301-315.
7. Heise, C. E.; Pahuja, A.; Hudson, S. C.; Mistry, M. S.; Putnam, A. L.; Gross, M. M.; Gottlieb, P. A.; Wade, W. S.; Kiankarimi, M.; Schwarz, D.; Crowe, P.; Zlotnik, A.; Alleva, D. G. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist J. Pharmacol. Exp. Ther. 2005, 313, 1263-1271
8. O'Boyle, G.; Fox, C. R.; Walden, H. R.; Willet, J. D.; Mavin, E. R.; Hine, D. W.; Palmer, J. M.; Barker, C. E.; Lamb, C. A.; Ali, S.; Kirby, J. A. Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 4598-4603
9. Yates, C. C.; Krishna, P.; Whaley, D.; Bodnar, R.; Turner, T.; Wells, A. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring Am. J. Pathol. 2010, 176, 1743-1755
10. Stroke, I. L.; Cole, A. G.; Simhadri, S.; Brescia, M. R.; Desai, M.; Zhang, J. J.; Merritt, J. R.; Appell, K. C.; Henderson, I.; Webb, M. L. Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries Biochem. Biophys. Res. Commun. 2006, 349, 221-228
11. Anghelescu, A. V.; DeLisle, R. K.; Lowrie, J. F.; Klon, A. E.; Xie, X.; Diller, D. J. Technique for generating three-dimensional alignments of multiple ligands from one-dimensional alignments J. Chem. Inf. Model. 2008, 48, 1041-1054
12. Nedjai, B.; Li, H.; Stroke, I. L.; Wise, E. L.; Webb, M. L.; Merritt, J. R.; Henderson, I.; Klon, A. E.; Cole, A. G.; Horuk, R.; Vaidehi, N.; Pease, J. E. Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3 Br. J. Pharmacol. 2012, 166, 912-923
13. Scholten, D.; Canals, M.; Wijtmans, M.; de Munnik, S.; Nguyen, P.; Verzijl, D.; de Esch, I.; Vischer, H.; Smit, M.; Leurs, R. Pharmacological characterisation of a small-molecule agonist for the chemokine receptor CXCR3 Br. J. Pharmacol. 2012, 166, 898-911
14. Wu, B.; Chien, E. Y. T.; Mol, C. D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F. C.; Hamel, D. J.; Kuhn, P.; Handel, T. M.; Cherezov, V.; Stevens, R. C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 2010, 330, 1066-1071
15. Roumen, L.; Sanders, M. P. A.; Vroling, B.; De Esch, I. J. P.; De Vlieg, J.; Leurs, R.; Klomp, J. P. G.; Nabuurs, S. B.; De Graaf, C. In silico veritas: the pitfalls and challenges of predicting GPCR-ligand interactions Pharmaceuticals 2011, 4, 1196-1215
16. Kufareva, I.; Rueda, M.; Katritch, V.; Stevens, R. C.; Abagyan, R. Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment Structure 2011, 19, 1108-1126
17. Wijtmans, M.; Verzijl, D.; Bergmans, S.; Lai, M.; Bosch, L.; Smit, M. J.; de Esch, I. J. Leurs, R. CXCR3 antagonists: quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors Bioorg. Med. Chem. 2011, 19, 3384-3393
18. Oyler, K. D.; Coughlin, F. J.; Bernhard, S. Controlling the helicity of 2,2′-bipyridyl ruthenium(II) and zinc(II) hemicage complexes J. Am. Chem. Soc. 2007, 129, 210-217
19. Brown, H. C.; Dhokte, U. P. Hydroboration. 90. Synthesis of 2-isobutyl- and 2-isopropylapopinenes. Rates and stoichiometry of the hydroboration of 2-organylapopinenes with borane-methyl sulfide and borane-tetrahydrofuran J. Org. Chem. 1994, 59, 2025-2032
20. Simoni, D.; Giannini, G.; Roberti, M.; Rondanin, R.; Baruchello, R.; Rossi, M.; Grisolia, G.; Invidiata, F. P.; Aiello, S.; Marino, S.; Cavallini, S.; Siniscalchi, A.; Gebbia, N.; Crosta, L.; Grimaudo, S.; Abbadessa, V.; Di Cristina, A.; Tolomeo, M. Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells J. Med. Chem. 2005, 48, 4293-4299
21. Wijtmans, M.; Verzijl, D.; van Dam, C. M.; Bosch, L.; Smit, M. J.; Leurs, R.; de Esch, I. J. Exploring a pocket for polycycloaliphatic groups in the CXCR3 receptor with the aid of a modular synthetic strategy Bioorg. Med. Chem. Lett. 2009, 19, 2252-2257
22. Grein, F. Twist angles and rotational energy barriers of biphenyl and substituted biphenyls J. Phys. Chem. A 2002, 106, 3823-3827
23. Karpfen, A.; Choi, C. H.; Kertesz, M. Single-bond torsional potentials in conjugated systems: a comparison of ab initio and density functional results J. Phys. Chem. A 1997, 101, 7426-7433
24. Lipsitz, R. S.; Tjandra, N. Residual dipolar couplings in NMR structure analysis Annu. Rev. Biophys. Biomol. Struct. 2004, 33, 387-413
25. Anet, F. A. L.; Bourn, A. J. R. Nuclear magnetic resonance spectral assignments from nuclear Overhauser effects J. Am. Chem. Soc. 1965, 87, 5250-5251
26. Veyrat, M.; Maury, O.; Faverjon, F.; Over, D. E.; Ramasseul, R.; Marchon, J.-C.; Turowska-Tyrk, I.; Scheidt, W. R. Chiroporphyrins: an approach to asymmetric catalysts with stereocenters near the plane of the porphyrin ring Angew. Chem., Int. Ed. Engl. 1994, 33, 220-223
27. Hardegger, L. A.; Kuhn, B.; Spinnler, B.; Anselm, L.; Ecabert, R.; Stihle, M.; Gsell, B.; Thoma, R.; Diez, J.; Benz, J.; Plancher, J. M.; Hartmann, G.; Banner, D. W.; Haap, W.; Diederich, F. Systematic investigation of halogen bonding in protein-ligand interactions Angew. Chem., Int. Ed. 2011, 50, 314-318
28. Parisini, E.; Metrangolo, P.; Pilati, T.; Resnati, G.; Terraneo, G. Halogen bonding in halocarbon-protein complexes: a structural survey Chem. Soc. Rev. 2011, 40, 2267-2278
29. Stumpfe, D.; Bajorath, J. Exploring activity cliffs in medicinal chemistry J. Med. Chem. 2012, 55, 2932-2942
30. Iyer, P.; Stumpfe, D.; Bajorath, J. Molecular mechanism-based network-like similarity graphs reveal relationships between different types of receptor ligands and structural changes that determine agonistic, inverse-agonistic, and antagonistic effects J. Chem. Inf. Model. 2011, 51, 1281-1286
31. Wise, E.; Pease, J. E. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism? Biochem. Soc. Trans. 2007, 35, 755-759
32. Anderskewitz, R.; Bauer, R.; Bodenbach, G.; Gester, D.; Gramlich, B.; Morschhauser, G.; Birke, F. W. Pyrrolidinohydroquinazolines-a novel class of CCR3 modulators Bioorg. Med. Chem. Lett. 2005, 15, 669-673
33. Ting, P. C.; Umland, S. P.; Aslanian, R.; Cao, J.; Garlisi, C. G.; Huang, Y.; Jakway, J.; Liu, Z.; Shah, H.; Tian, F.; Wan, Y.; Shih, N. Y. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists Bioorg. Med. Chem. Lett. 2005, 15, 3020-3023
34. Ferain, T.; Hoveyda, H.; Ooms, F.; Schols, D.; Bernard, J.; Fraser, G. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication J. Pharmacol. Exp. Ther. 2011, 337, 655-662
35. i-protein pathway activation Biochem. Biophys. Res. Commun. 2012, 419, 412-418
36. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Cliffordaaa, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, revision C.02; Gaussian, Inc.: Wallingford, CT, 2004.